PP002. Study of polymorphisms of the adiponectin gene in women with gestational hypertension and preeclampsia

• Published in: Pregnancy hypertension Vol. 2; no. 3; p. 241
• Main Authors: Machado, J.S.R, Cavalli, R.C, Sandrim, V.C, Palei, A.C.T, Amaral, L.M, Bueno, A.C, Antonini, S.R.R, Tanus Santos, J.E, Duarte, G
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.07.2012
• Subjects: Cardiovascular; Obstetrics and Gynecology
• ISSN: 2210-7789; 2210-7797
• DOI: 10.1016/j.preghy.2012.04.113

Introduction Adiponectin is involved in energy homeostasis by regulating glucose and lipid metabolism. Additionally, it presents anti-inflammatory and anti-atherosclerotic functions. Polymorphisms in adiponectin gene (ADIPOQ) can modulate the concentrations of adiponectin. The influence of these polymorphisms on the development of gestational hypertension (GH) and preeclampsia (PE) is unknown. Objectives The aim of this work was to examine the influence of polymorphisms in the gene ADIPOQ on the development of gestational hypertension and preeclampsia. Methods: Patients and methods We studied 401 pregnant women: 161 healthy pregnant (HP), 113 pregnant with gestational hypertension (GH) and 127 pregnant with preeclampsia (PE). Polymorphisms ADIPOQ −11391G > A (rs17300539), −11377C > G (rs266729), 45T > G (rs2241766) and 276G > T (rs1501299) were genotyped by allelic discrimination by PCR in real time. Haplotypes were inferred using the PHASE 2.1 program. Results There were no statistically significant differences in allele and genotype frequencies of the polymorphisms studied. In the analysis of haplotypes, we observed small differences in haplotype frequencies between groups, however, none of these differences was statistically significant ( P > 0.05). Conclusion We found no association between the genotypic and allelic variants of the ADIPOQ gene polymorphisms with the development of gestational hypertension and preeclampsia.